Cingulate products

Cingulate - Precision Timed Release (PTR) Drug

CTx-1302 utilizes a breakthrough multi-core formulation of dextroamphetamine, a compound approved by the FDA for the treatment of ADHD.

Cingulate - Precision Timed Release (PTR) Drug

CTx-1301 utilizes a breakthrough multi-core formulation of dexmethylphenidate, a compound approved by the FDA for the treatment of ADHD.

Cingulate - Technology

Cingulate is developing ADHD medications capable of achieving precise once-daily dosing using a novel erosion based controlled release technology that provides unrivaled control of drug release.